Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abatement, absence, Absent, accretion, Ajovy, Allentown, Alliance, antidepressant, appeal, architecture, bankruptcy, BEAT, beta, bid, blind, Blueprint, branch, bundled, burn, capacity, capsule, capture, Chapter, Columbia, complaint, consecutive, constraint, coordination, core, CRL, crossing, Cymbalta, de, deferral, delist, delisted, delisting, Demitrack, deposit, Dickinson, disorder, District, DOR, double, dual, duloxetine, duty, Eastern, eating, ECG, EDPA, Effexor, electroencephalography, Emgality, Emory, energy, enrichment, entirety, equitable, erosion, EU, evoked, exacerbated, expedient, factor, faculty, faster, fatigue, fed, fellowship, fibromyalgia, fiduciary, float, Francisco, fundraising, gather, GGRP, gold, great, Hamill, hearing, HHS, hindsight, idiopathic, incentivize, incremental, injunctive, Inspector, IQVIA, IRS, Jersey, Jiangsu, Judge, lethargy, licensee, Mark, master, Mental, metabolite, metatarsal, Michigan, misleading, monotherapy, month, MOR, NCE, NephroGenex, neuroendocrine, neuroendocrinology, Neuropsychopharmacology, NeuroStar, Nhwa, NIDA, official, Orexigen, organizational, outnumber, pharmacodynamic, Pharmbio, plaintiff, pocket, postsurgical, predominant, Presidential, Psychiatric, psychiatrist, psychiatry, purported, QT, qualitative, quantitative, regained, rental, reorganization, resubmission, Roivant, sequelae, shareholder, spanning, St, structure, sublease, subleased, sublingual, sufantanil, supratherapeutic, Symphony, syndrome, TCJA, television, temperature, tenant, TMS, truthful, unclear, unconditional, unconstitutional, unjust, unspecified, Vanguard, variable, vigorously, vital, volunteer, Wainwright, withholding, Wood, XR, Yoder
Removed:
activating, administering, Adolor, AEs, affiliate, age, Akebia, Akzo, allocating, analyst, angiotensin, beneficially, bio, Biochemistry, black, Bone, borrowing, Braunfeld, Bristol, calling, cell, center, Cephalon, CFA, charterholder, Chase, Cigna, Cohen, collateralized, collectibility, composite, contrast, convene, Cooper, copy, Cornell, cornerstone, Cuca, David, DC, deliverable, diclofenac, displaced, displayed, divestiture, division, DYLOJECT, EMA, Endo, enzyme, episodic, Esq, Excellence, existence, fertility, founding, funded, Genome, GlaxoSmithKline, Gowen, GSK, Habib, Idera, Ikaria, influencing, inhibiting, intensive, interaction, JPMorgan, Kingdom, KPMG, leadership, leased, Lecturer, Lefkowitz, Limongelli, liver, Maryland, Maxine, metabolic, metabolizer, minute, Morgan, NE, negotiation, Nobel, noncash, ordinary, Organon, Oxley, parenteral, poor, predominantly, Princeton, proportional, prospectively, QTc, recovered, recurring, reject, repurchase, room, Royer, Secretary, separating, serving, Sheffield, Squibb, Stern, Street, suggesting, supported, Temple, tenure, tranched, Treasurer, undelivered, Washington, Wharton, worked, world, Yacoub, York
Filing tables
Filing exhibits
Related press release
Associated TRVN transcripts
TRVN similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-00000) pertaining to the 2013 Equity Incentive Plan of Trevena, Inc. of our report dated March 13, 2019, with respect to the financial statements of Trevena, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2018, filed with the Securities and Exchange Commission.
|
|
| /s/ Ernst & Young LLP |
|
|
Philadelphia, Pennsylvania
March 13, 2019